195 related articles for article (PubMed ID: 23371966)
1. Potential role of UGT1A4 promoter SNPs in anastrozole pharmacogenomics.
Edavana VK; Dhakal IB; Williams S; Penney R; Boysen G; Yao-Borengasser A; Kadlubar S
Drug Metab Dispos; 2013 Apr; 41(4):870-7. PubMed ID: 23371966
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction.
Rowland A; Elliot DJ; Williams JA; Mackenzie PI; Dickinson RG; Miners JO
Drug Metab Dispos; 2006 Jun; 34(6):1055-62. PubMed ID: 16565174
[TBL] [Abstract][Full Text] [Related]
3. A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivatives.
Greer AK; Dates CR; Starlard-Davenport A; Edavana VK; Bratton SM; Dhakal IB; Finel M; Kadlubar SA; Radominska-Pandya A
Drug Metab Dispos; 2014 Sep; 42(9):1392-400. PubMed ID: 24917585
[TBL] [Abstract][Full Text] [Related]
4. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronidation phenotype in human liver microsomes.
Wiener D; Fang JL; Dossett N; Lazarus P
Cancer Res; 2004 Feb; 64(3):1190-6. PubMed ID: 14871856
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole.
Kamdem LK; Liu Y; Stearns V; Kadlubar SA; Ramirez J; Jeter S; Shahverdi K; Ward BA; Ogburn E; Ratain MJ; Flockhart DA; Desta Z
Br J Clin Pharmacol; 2010 Dec; 70(6):854-69. PubMed ID: 21175441
[TBL] [Abstract][Full Text] [Related]
6. Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites.
Zhou J; Tracy TS; Remmel RP
Drug Metab Dispos; 2010 Mar; 38(3):431-40. PubMed ID: 20007295
[TBL] [Abstract][Full Text] [Related]
7. Effect of MRP2 and MRP3 Polymorphisms on Anastrozole Glucuronidation and MRP2 and MRP3 Gene Expression in Normal Liver Samples.
Edavana VK; Penney RB; Yao-Borengasser A; Starlard-Davenport A; Dhakal IB; Kadlubar S
Int J Cancer Res Mol Mech; 2015 Oct; 1(3):. PubMed ID: 26985457
[TBL] [Abstract][Full Text] [Related]
8. Glucuronidation of Abiraterone and Its Pharmacologically Active Metabolites by UGT1A4, Influence of Polymorphic Variants and Their Potential as Inhibitors of Steroid Glucuronidation.
Vaillancourt J; Turcotte V; Caron P; Villeneuve L; Lacombe L; Pouliot F; Lévesque É; Guillemette C
Drug Metab Dispos; 2020 Feb; 48(2):75-84. PubMed ID: 31727674
[TBL] [Abstract][Full Text] [Related]
9. The influence of genetic polymorphisms on the efficacy and side effects of anastrozole in postmenopausal breast cancer patients.
Abubakar MB; Wei K; Gan SH
Pharmacogenet Genomics; 2014 Dec; 24(12):575-81. PubMed ID: 25203739
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy.
Chen H; Yang K; Choi S; Fischer JH; Jeong H
Drug Metab Dispos; 2009 Sep; 37(9):1841-7. PubMed ID: 19546240
[TBL] [Abstract][Full Text] [Related]
11. Frequencies of UGT1A4*2 (P24T) and *3 (L48V) and their effects on serum concentrations of lamotrigine.
Reimers A; Sjursen W; Helde G; Brodtkorb E
Eur J Drug Metab Pharmacokinet; 2016 Apr; 41(2):149-55. PubMed ID: 25492569
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of UGT1A4(P24T) and UGT1A4(L48V) variant enzymes.
Zhou J; Argikar UA; Remmel RP
Pharmacogenomics; 2011 Dec; 12(12):1671-9. PubMed ID: 22047493
[TBL] [Abstract][Full Text] [Related]
13. The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.
Gulcebi MI; Ozkaynakcı A; Goren MZ; Aker RG; Ozkara C; Onat FY
Epilepsy Res; 2011 Jun; 95(1-2):1-8. PubMed ID: 21601426
[TBL] [Abstract][Full Text] [Related]
14. Role of human UGT2B10 in N-glucuronidation of tricyclic antidepressants, amitriptyline, imipramine, clomipramine, and trimipramine.
Zhou D; Guo J; Linnenbach AJ; Booth-Genthe CL; Grimm SW
Drug Metab Dispos; 2010 May; 38(5):863-70. PubMed ID: 20133892
[TBL] [Abstract][Full Text] [Related]
15. Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants.
Sun D; Chen G; Dellinger RW; Duncan K; Fang JL; Lazarus P
Breast Cancer Res; 2006; 8(4):R50. PubMed ID: 16884532
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients.
Gervasini G; Jara C; Olier C; Romero N; Martínez R; Carrillo JA
Br J Clin Pharmacol; 2017 Mar; 83(3):562-571. PubMed ID: 27747906
[TBL] [Abstract][Full Text] [Related]
17. Expression of UDP-glucuronosyltransferase 1A4 in human placenta at term.
Reimers A; Østby L; Stuen I; Sundby E
Eur J Drug Metab Pharmacokinet; 2011 Jan; 35(3-4):79-82. PubMed ID: 21302032
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine metabolism and the significance of UGT1A448V and UGT2B1067Y variants.
Erickson-Ridout KK; Zhu J; Lazarus P
Pharmacogenet Genomics; 2011 Sep; 21(9):539-51. PubMed ID: 21750471
[TBL] [Abstract][Full Text] [Related]
19. Effects of UGT1A4 genetic polymorphisms on serum lamotrigine concentrations in Chinese children with epilepsy.
Wang Q; Liang M; Dong Y; Yun W; Qiu F; Zhao L; Guo Y
Drug Metab Pharmacokinet; 2015 Jun; 30(3):209-13. PubMed ID: 25922177
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of 1'- and 4-hydroxymidazolam by glucuronide conjugation is largely mediated by UDP-glucuronosyltransferases 1A4, 2B4, and 2B7.
Seo KA; Bae SK; Choi YK; Choi CS; Liu KH; Shin JG
Drug Metab Dispos; 2010 Nov; 38(11):2007-13. PubMed ID: 20713656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
